Over the past year, AI-powered technology has become more and more commonplace across the pharmaceutical industry. Abid Rahman, senior vice president of innovation at EVERSANA, spoke with Pharmaceutical Executive about some of the various sectors where the technology has been introduced and how it’s working.
Pharmaceutical Executive: How is AI being utilized for product launches?
Abid Rahman: Use cases for AI continue to evolve, but there are many ways this technology is currently being used for product launches in pharma.
First, AI leverages historical data and market trends to forecast a product’s potential success. By analyzing real-world and claims data, AI platforms provide valuable insights for informed decision-making.
Additionally, AI enhances branding campaigns by identifying new audience segments quickly and accurately. This allows for the development and deployment of tailored messaging and visuals at an unprecedented speed. Generative AI also assists in creating initial drafts of text and images for promotional materials, ensuring the right tone, and targeting.
And finally, AI plays a crucial role in disseminating information during a product launch. It helps identify patient and HCP audiences, select the appropriate channels, and create engaging content. AI-powered solutions include conversational chatbots, AI-generated videos with avatars, and other synthetic content to effectively connect with audiences.
Read more of this article from PharmaExec.com
Connect With An Expert!
To learn more about integrating these AI-driven strategies into your brand, get in touch!
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…